SCHEMBL6135136

SCHEMBL6135136

CCOC(=O)c1ccc(-c2cnc3sc(-c4ccc(OC5CCN(c6ccccc6)CC5)cc4)nn23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 8/20 0.47
MKNK2 Q9HBH9 8/20 0.47
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
RARA P10276 1/20 0.41
RARB P10826 1/20 0.41
RARG P13631 1/20 0.41
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 1/20 0.40
FFAR4 Q5NUL3 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FFAR1 O14842 1/20 0.39
FAAH O00519 1/20 0.38
LMNA P02545 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134521 0.89 MKNK1 (0.45) MKNK1MKNK2FFAR4FFAR1EPHX2
SCHEMBL6134929 0.85 MKNK1 (0.47) MKNK1MKNK2ALDH1A1
SCHEMBL6135144 0.85 MKNK1 (0.47) MKNK1MKNK2
SCHEMBL6134597 0.85 MKNK1 (0.48) MKNK1MKNK2RARARARBRARG
SCHEMBL6134954 0.83 MKNK1 (0.47) MKNK1MKNK2MAPTALDH1A1TSHR
SCHEMBL6135134 0.83 TP53 (0.44) CCNCCDK8RARARARBRARG
SCHEMBL6135447 0.82 ALDH1A1 (0.55) CCNCCDK8MAPTALDH1A1TSHR
SCHEMBL6135026 0.80 MKNK1 (0.47) MKNK1MKNK2
SCHEMBL6134291 0.80 MKNK1 (0.43) MKNK1MKNK2MAPTFFAR1EPHX2
SCHEMBL6134883 0.79 HDAC3 (0.51) MKNK1MKNK2MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 MKNK1 2695/4885MKNK2 3220/4885CCNC 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.